Latest Breaking News On - Rises 233 pileptiques - Page 1 : comparemela.com

Dijon, France, February 1, 2024 18:15 CET - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free.

Sophie baumontNatasha drapeauPatrick alexandreDevelopment authorityCohesion bureauBiomedical advanced researchSyneos healthExecutive chairmanOlivier gireSpecialty pharmaAdvanced researchParis stock exchange alcjCommercial strategyEpileptic seizuresTrat 233 gie commercialeRises 233 pileptiques